Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia.

Lozano ML, Mingot-Castellano ME, Perera MM, Jarque I, Campos-Alvarez RM, González-López TJ, Carreño-Tarragona G, Bermejo N, Lopez-Fernandez MF, de Andrés A, Valcarcel D, Casado-Montero LF, Alvarez-Roman MT, Orts MI, Novelli S, Revilla N, González-Porras JR, Bolaños E, Rodríguez-López MA, Orna-Montero E, Vicente V.

Sci Rep. 2019 Nov 13;9(1):16680. doi: 10.1038/s41598-019-53209-y.

2.

The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.

Fernández-Navarro P, López-Nieva P, Piñeiro-Yañez E, Carreño-Tarragona G, Martinez-López J, Sánchez Pérez R, Aroca Á, Al-Shahrour F, Cobos-Fernández MÁ, Fernández-Piqueras J.

BMC Cancer. 2019 Oct 26;19(1):1005. doi: 10.1186/s12885-019-6209-9.

3.

Protein Carbonylation in Patients with Myelodysplastic Syndrome: An Opportunity for Deferasirox Therapy.

Rodríguez-García A, Morales ML, Garrido-García V, García-Baquero I, Leivas A, Carreño-Tarragona G, Sánchez R, Arenas A, Cedena T, Ayala RM, Bautista JM, Martínez-López J, Linares M.

Antioxidants (Basel). 2019 Oct 24;8(11). pii: E508. doi: 10.3390/antiox8110508.

4.

The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1.

Sainz de Aja J, Menchero S, Rollan I, Barral A, Tiana M, Jawaid W, Cossio I, Alvarez A, Carreño-Tarragona G, Badia-Careaga C, Nichols J, Göttgens B, Isern J, Manzanares M.

EMBO J. 2019 Apr 1;38(7). pii: e99122. doi: 10.15252/embj.201899122. Epub 2019 Feb 27.

5.

Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia.

Cross NCP, Hoade Y, Tapper WJ, Carreno-Tarragona G, Fanelli T, Jawhar M, Naumann N, Pieniak I, Lübke J, Ali S, Bhuller K, Burgstaller S, Cargo C, Cavenagh J, Duncombe AS, Das-Gupta E, Evans P, Forsyth P, George P, Grimley C, Jack F, Munro L, Mehra V, Patel K, Rismani A, Sciuccati G, Thomas-Dewing R, Thornton P, Virchis A, Watt S, Wallis L, Whiteway A, Zegocki K, Bain BJ, Reiter A, Chase A.

Leukemia. 2019 Feb;33(2):415-425. doi: 10.1038/s41375-018-0342-3. Epub 2018 Dec 20.

6.

Essential thrombocythaemia with mutation in MPL: clinicopathological correlation and comparison with JAK2V617F-mutated and CALR-mutated genotypes.

Alvarez-Larran A, Martínez D, Arenillas L, Rubio A, Arellano-Rodrigo E, Hernández Boluda JC, Papaleo N, Caballero G, Martínez C, Ferrer-Marín F, Mata MI, Pérez-Encinas M, Durán MA, Alonso JM, Carreño-Tarragona G, Alonso JM, Noya S, Magro E, Pérez R, López-Guerra M, Pastor-Galán I, Cervantes F, Besses C, Colomo L, Rozman M.

J Clin Pathol. 2018 Nov;71(11):975-980. doi: 10.1136/jclinpath-2018-205227. Epub 2018 Jun 22.

PMID:
29934356
7.

Fatal graft-versus-host disease after allogeneic stem cell transplantation in a patient recently exposed to nivolumab.

Jiménez-Ubieto A, Rodriguez A, Martinez Sánchez P, Gómez A, Rodriguez Y, Carreño-Tarragona G, Martinez-López J, Grande C.

J Oncol Pharm Pract. 2017 Jan 1:1078155217743069. doi: 10.1177/1078155217743069. [Epub ahead of print]

PMID:
29207936
8.

Dramatic resolution of disseminated pyoderma gangrenosum associated with monoclonal gammopathy after therapy with bortezomib and dexamethasone.

Velasco-Tamariz V, Carreño-Tarragona G, Tous-Romero F, Gil-de la Cruz E, Martín-Clavero E, Rivera-Díaz R.

Int Wound J. 2017 Dec;14(6):1382-1384. doi: 10.1111/iwj.12746. Epub 2017 Mar 29.

PMID:
28371346
9.

Lupus anticoagulant-hypoprothrombinemia syndrome: A rare association in systemic lupus erythematosus.

Carreño-Tarragona G, Morales E, Jiménez-Herrero MC, Cortés-Fornieles E, Gutierrez E, Praga M.

Nefrologia. 2016;36(2):186-8. doi: 10.1016/j.nefro.2015.05.027. Epub 2015 Aug 4. English, Spanish. No abstract available.

10.

Antiphospholipid syndrome in a patient suffering from congenital dyserythropoietic anemia type III.

Carreno-Tarragona G, Trapiello-Valbuena F, Aranda-Salom J, Martínez-López J, Lumbreras C, Oliveira-Ramírez E, Díaz-Pedroche C.

Ann Hematol. 2015 Aug;94(8):1411-2. doi: 10.1007/s00277-015-2379-y. Epub 2015 Apr 22. No abstract available.

PMID:
25900788
11.

Effects of age and caloric restriction on the cardiac and coronary response to endothelin-1 in rats.

Granado M, Rubio C, Amor S, Monge L, Fernández N, Carreño-Tarragona G, Carrascosa JM, García-Villalón ÁL.

Exp Gerontol. 2014 Dec;60:183-9. doi: 10.1016/j.exger.2014.10.018. Epub 2014 Nov 1.

PMID:
25446983
12.

Purinergic component in the coronary vasodilatation to acetylcholine after ischemia-reperfusion in perfused rat hearts.

García-Villalón ÁL, Granado M, Monge L, Fernández N, Carreño-Tarragona G, Amor S.

J Vasc Res. 2014;51(4):283-9. doi: 10.1159/000365928. Epub 2014 Sep 16.

PMID:
25228127
13.

Long-term effects of early overnutrition in the heart of male adult rats: role of the renin-angiotensin system.

Granado M, Fernández N, Monge L, Carreño-Tarragona G, Figueras JC, Amor S, García-Villalón AL.

PLoS One. 2013 Jun 3;8(6):e65172. doi: 10.1371/journal.pone.0065172. Print 2014.

14.

Effects of coronary ischemia-reperfusion in a rat model of early overnutrition. Role of angiotensin receptors.

Granado M, Fernández N, Monge L, Figueras JC, Carreño-Tarragona G, Amor S, García-Villalón AL.

PLoS One. 2013;8(2):e54984. doi: 10.1371/journal.pone.0054984. Epub 2013 Feb 1.

15.

Coronary response to diadenosine triphosphate after ischemia-reperfusion in the isolated rat heart.

García-Villalón AL, Fernández N, Monge L, Granado M, Carreño-Tarragona G, Figueras JC, Diéguez G.

Exp Biol Med (Maywood). 2012 Aug;237(8):966-72. doi: 10.1258/ebm.2012.012006. Epub 2012 Aug 13.

PMID:
22890026

Supplemental Content

Loading ...
Support Center